Press releases

Sachi Bio's lead program NI112 shows excellent Safety-Toxicity, brain-delivery, and biodistribution profile in Investigational New Drug...

"Sachi Bio has successfully advanced it's lead program towards translation for a range of neurodegenerative diseases, as well as a...